Abstract
INTRODUCTION AND OBJECTIVE:Given the long natural history of prostate cancer (PC), intermediate clinical endpoints (ICEs) might aid in study design and expedite drug approvals, if surrogacy is met....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
